These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21092391

  • 1. Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis.
    Boelaert M, Meheus F, Robays J, Lutumba P.
    Ann Trop Med Parasitol; 2010 Oct; 104(7):535-42. PubMed ID: 21092391
    [Abstract] [Full Text] [Related]

  • 2. Leishmaniasis and poverty.
    Alvar J, Yactayo S, Bern C.
    Trends Parasitol; 2006 Dec; 22(12):552-7. PubMed ID: 17023215
    [Abstract] [Full Text] [Related]

  • 3. Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas disease.
    Lenk EJ, Redekop WK, Luyendijk M, Fitzpatrick C, Niessen L, Stolk WA, Tediosi F, Rijnsburger AJ, Bakker R, Hontelez JAC, Richardus JH, Jacobson J, Le Rutte EA, de Vlas SJ, Severens JL.
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006250. PubMed ID: 29534061
    [Abstract] [Full Text] [Related]

  • 4. The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.
    Boelaert M, Meheus F, Sanchez A, Singh SP, Vanlerberghe V, Picado A, Meessen B, Sundar S.
    Trop Med Int Health; 2009 Jun; 14(6):639-44. PubMed ID: 19392741
    [Abstract] [Full Text] [Related]

  • 5. When the market fails, the poor pay.
    Patnaik MM, Stauffer WM, Campagna A, Stauffer CI, Walker PF.
    Minn Med; 2007 Mar; 90(3):38-40. PubMed ID: 17432756
    [No Abstract] [Full Text] [Related]

  • 6. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P.
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [Abstract] [Full Text] [Related]

  • 7. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
    Meheus F, Abuzaid AA, Baltussen R, Younis BM, Balasegaram M, Khalil EAG, Boelaert M, Musa AM.
    Am J Trop Med Hyg; 2013 Dec; 89(6):1146-1153. PubMed ID: 24189368
    [Abstract] [Full Text] [Related]

  • 8. The economic burden of visceral leishmaniasis for households in Nepal.
    Rijal S, Koirala S, Van der Stuyft P, Boelaert M.
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):838-41. PubMed ID: 16406035
    [Abstract] [Full Text] [Related]

  • 9. Recent Theoretical Studies Concerning Important Tropical Infections.
    Scotti MT, Monteiro AFM, de Oliveira Viana J, Bezerra Mendonça Junior FJ, Ishiki HM, Tchouboun EN, De Araújo RSA, Scotti L.
    Curr Med Chem; 2020 Sep; 27(5):795-834. PubMed ID: 31296154
    [Abstract] [Full Text] [Related]

  • 10. Novel Financing Model for Neglected Tropical Diseases: Development Impact Bonds Applied to Sleeping Sickness and Rabies Control.
    Welburn SC, Bardosh KL, Coleman PG.
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005000. PubMed ID: 27855156
    [No Abstract] [Full Text] [Related]

  • 11. Socioeconomic Inequalities in Neglected Tropical Diseases: A Systematic Review.
    Houweling TA, Karim-Kos HE, Kulik MC, Stolk WA, Haagsma JA, Lenk EJ, Richardus JH, de Vlas SJ.
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004546. PubMed ID: 27171166
    [Abstract] [Full Text] [Related]

  • 12. Neglected tropical diseases: now more than just 'other diseases'--the post-2015 agenda.
    Molyneux DH.
    Int Health; 2014 Sep; 6(3):172-80. PubMed ID: 24969646
    [Abstract] [Full Text] [Related]

  • 13. Economic inequality caused by feedbacks between poverty and the dynamics of a rare tropical disease: the case of Buruli ulcer in sub-Saharan Africa.
    Garchitorena A, Ngonghala CN, Guegan JF, Texier G, Bellanger M, Bonds M, Roche B.
    Proc Biol Sci; 2015 Nov 07; 282(1818):20151426. PubMed ID: 26538592
    [Abstract] [Full Text] [Related]

  • 14. Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review.
    Sunyoto T, Boelaert M, Meheus F.
    Expert Rev Anti Infect Ther; 2019 Jan 07; 17(1):57-69. PubMed ID: 30513027
    [Abstract] [Full Text] [Related]

  • 15. Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity.
    Strømme EM, Baerøe K, Norheim OF.
    Dev World Bioeth; 2014 Dec 07; 14(3):132-41. PubMed ID: 23724925
    [Abstract] [Full Text] [Related]

  • 16. Projects set to tackle neglected diseases.
    Hayden EC.
    Nature; 2014 Jan 09; 505(7482):142. PubMed ID: 24402261
    [No Abstract] [Full Text] [Related]

  • 17. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences.
    Adhikari SR, Maskay NM, Sharma BP.
    Health Policy Plan; 2009 Mar 09; 24(2):129-39. PubMed ID: 19181674
    [Abstract] [Full Text] [Related]

  • 18. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A, Morán-Serradilla C, Angulo-Elizari E, Sanmartín C, Plano D.
    Eur J Med Chem; 2023 Jan 15; 246():115002. PubMed ID: 36493616
    [Abstract] [Full Text] [Related]

  • 19. Turning neglected tropical diseases into forgotten maladies.
    Musgrove P, Hotez PJ.
    Health Aff (Millwood); 2009 Jan 15; 28(6):1691-706. PubMed ID: 19887410
    [Abstract] [Full Text] [Related]

  • 20. The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India.
    Sarnoff R, Desai J, Desjeux P, Mittal A, Topno R, Siddiqui NA, Pandey A, Sur D, Das P.
    Trop Med Int Health; 2010 Jul 15; 15 Suppl 2():42-9. PubMed ID: 20487423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.